A newly-awarded U.S. patent, with fantastic ramifications for cures and treatments of conditions including Parkinson’s Disease, is further evidence of the importance of the recent lawsuit seeking to halt federal grants for embryonic research.
After seven years, Kansas State University’s Research Foundation has obtained proprietary rights for obtaining, culturing and banking “matrix” stem cells from the cushioning material (‘Wharton’s jelly’) inside umbilical cords, both human and animal.
Some of the purposes for these K-State-patented stem cells will be repairing nerve damage, cardiac muscle, and blood vessels.
Grants from the National Institute of Health (NIH) helped the researchers achieve this breakthough in accessing a plentiful source of reparative stem cells that do not involve the destruction of embryos. (more…)